Skip to content
SeraNovo company logo for pharmaceutical formulation technology brand.
  • About SeraNovo
  • Home
  • Technology
  • Applying NanoGlass™
    • Pre-Clinical and Clinical
Formulations
    • GLP Tox Formulations
  • Media Center
    • Articles and Videos
    • Press releases
    • Careers
  • Contact Us
  • About SeraNovo
  • Home
  • Technology
  • Applying NanoGlass™
    • Pre-Clinical and Clinical
Formulations
    • GLP Tox Formulations
  • Media Center
    • Articles and Videos
    • Press releases
    • Careers
  • Contact Us
  • About SeraNovo
  • Home
  • Technology
  • Applying NanoGlass™
    • Pre-Clinical and Clinical
Formulations
    • GLP Tox Formulations
  • Media Center
    • Articles and Videos
    • Press releases
    • Careers
  • Contact Us
  • About SeraNovo
  • Home
  • Technology
  • Applying NanoGlass™
    • Pre-Clinical and Clinical
Formulations
    • GLP Tox Formulations
  • Media Center
    • Articles and Videos
    • Press releases
    • Careers
  • Contact Us
Contact Us

Joost Holthuis

  1. Home>
  2. Joost Holthuis
You are currently viewing Joost Holthuis

Joost Holthuis

Recent Posts

  • Article 7: Can PROTACs Truly Become Oral Drugs?
  • Article 6: The 3 Pillars of Bioavailability.
  • Webinar: Solving Bioavailability in Two Weeks
  • Article 5: A Formulation Perspective On Protein Degraders
  • Predicting In Vivo Performance Through In Vitro Partitioning

Recent Comments

No comments to show.
SeraNovo company logo for pharmaceutical formulation technology brand.

Useful Links

  • Home
  • Technology
  • Applying NanoGlass™
  • Media Center
  • Contact Us

Contact Details

info@seranovo.com

J.H Oortweg 21, 2333CH Leiden, The Netherlands

Follow Us

Linkedin Facebook
©2025, SeraNovo, All Rights Reserved

Contact Us

Visit us or contact us directly and get a response in 24h